ARIUS RESEARCH

ARIUS Research, Inc., a biotechnology company, engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia, and melanoma. It identifies monoclonal antibodies targeting various cancer indications through its technology platform, FunctionFIRST. The company's product pipeline includes CD63 program that is in preclinical studies for various cancer indications; ARH460-16-2, an antibody targeting t... he cancer stem cell antigen CD44; AR36A36.11.1 and AR10A304.7, which targets the complement-inhibitory molecule CD59; AR47A6.4.2 and AR52A301.5, which are monoclonal antibodies directed to the cancer-associated protein TROP-2 that is homologous to human EpCAM, an another cell surface cancer related protein; and AR40A746.2.3 that targets leukemia cancer stem cells. It also has antibody programs targeting the MCSP antigen and 37LRP. ARIUS has partnerships with Oxford BioMedica plc, Xerion Pharmaceuticals AG, PDL BioPharma, Inc., Medarex, Inc., Genentech, Inc., and Takeda Pharmaceutical Company Limited. The company was founded in 1999 and is based in Toronto, Canada. As of September 23, 2008, Arius Research Inc. operates as a subsidiary of Roche Holding AG.
ARIUS RESEARCH
Industry:
Biotechnology Health Care Hospital Therapeutics
Founded:
1999-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.ariusresearch.com
Total Employee:
11+
Status:
Closed
Contact:
416-862-2323
Total Funding:
23.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Nginx DoubleClick.Net CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Trellian
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Cocrystal Discovery
Cocrystal Discovery is a biotechnology company developing antiviral therapeutics for human diseases.
Intradigm Corporation
Intradigm Corporation is a biotechnology company developing systematic RNA interference therapeutics.
Lenstec
Lenstec is a biotechnology company located in Saint Petersburg.
Meditope Biosciences
Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.
NerveSolutions
NerveSolutions is a biomedical technology company innovating implantable nerve interface devices.
ORGANIC GENOMICS
ORGANIC GENOMICS is a biotechnology company for developing health care products of therapeutic proteins.
Current Employees Featured
Founder
Investors List
Efficacy Capital
Efficacy Capital investment in Venture Round - Arius Research
Xmark Opportunity Funds
Xmark Opportunity Funds investment in Venture Round - Arius Research
OrbiMed
OrbiMed investment in Venture Round - Arius Research
Xmark Asset Management
Xmark Asset Management investment in Venture Round - Arius Research
Official Site Inspections
http://www.ariusresearch.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney

More informations about "Arius Research"
ARIUS Research Inc. - Toronto, Canada - bionity.com
Feb 20, 2008 ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, โฆSee details»
Arius Research - Crunchbase Company Profile & Funding
ARIUS Research, Inc., a biotechnology company, engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic โฆSee details»
Home [www.www.argusresearch.com]
Housing Feeling Weight of Rates According to the National Association of Homebuilders, the expectations of homebuilders for future sales declined in January after six consecutive โฆSee details»
Argus Research Corporation
Argus Research is a leading independent investment research organization providing quality research since 1934. Argus analysts, economists, and portfolio strategists forecast and โฆSee details»
Benefits Of Argus
Woman-Owned Business. We are a division of Argus Investors' Counsel, Inc. (AIC). AIC has been certified as a Women's Business Enterprise by the Women Presidents' Educational Organization.See details»
ARIUS Research - Ownership and Business Overview | Mergr
Jul 23, 2008 ARIUS Research, Inc. is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the โฆSee details»
Argus Research - LinkedIn
Argus Research Financial Services Argus Research Co. provides objective, independent financial-market research, analytics, data and advice to investors.See details»
Argus Research - Crunchbase Company Profile & Funding
Argus Research is an investment and financial research company that offers bespoke study in risk analysis, equity and commodities market.See details»
Arius Research Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Arius Research Inc of Mississauga, ON. Get the latest business insights from Dun & Bradstreet.See details»
Argus Research Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Argus Research Corporation of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Argus Investors' Counsel
Argus Investors' Counsel Inc. (AIC) is the money management division of The Argus Research Group and has been an SEC-registered investment advisor since 1960. AIC specializes in โฆSee details»
About Argus - Argus Research
Argus Research Company (www.ArgusResearch.com) Argus Research is a forward-thinking, long-standing independent investment research firm that offers forecasts and ratings on the โฆSee details»
Argus Investors' Counsel : About Us
Argus Investors' Counsel is the asset management arm of The Argus Research Group. We specialize in equity investment management for institutional and private investors. Our clients โฆSee details»
Argus Research Group | Argus Group - ArgusVickers
The Argus Research Group of companies are a leading global provider of research, information and advice on shareholderโs equitySee details»
Home [www.www.www.www.argusresearch.com]
Options in Global Sovereign Debt The benchmark U.S. 10-year Treasury bond yield is near 4.5%. The yield was headed toward the key 5% threshold in April on hotter-than-expected inflation โฆSee details»
About Argus Research | IntelligentCrowd
Argus Research is a forward-thinking, long-standing independent investment research firm that offers forecasts and ratings on hundreds of leading blue chip companies and the U.S. โฆSee details»
Argus Research Corporation Company Profile -Sales, Contacts ...
Argus Research Corporation is located in New York, New York. This organization primarily operates in the Miscellaneous Publishing business / industry within the Printing, Publishing โฆSee details»
About Argus Research Corporation - moneyshow.com
Argus Research is a leading independent investment research organization providing quality research since 1934. Argus analysts, economists, and portfolio strategists forecast and โฆSee details»
ARGUS RESEARCH 2025 OUTLOOK
Dec 4, 2024 DISCLAIMER The Argus trademark, service mark and logo are the intellectual property of The Argus Research Group, Inc. Investing in any security or investment strategy โฆSee details»
Home [stocks.www.argusresearch.com]
Growth Forecast for Clean Energy The emergence of Artificial Intelligence and the growth of the data centers that support the process point toward robust prospects for the power generation โฆSee details»